Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $34.41 Analyst target: $48.08 Upside: 39.71%
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania.
See the full interactive analysis & chart →Informational only — not investment advice.